DNA Unlimited vs Budget Blinds

Budget Blinds is the sharper target right now, and it’s not close. The 3.5% royalty on a $775k AUV tells you these operators are running real businesses with real margin to protect—exactly the kind who pay for software that tightens scheduling, inventory, or back-office workflows. DNA Unlimited’s sub-$80k all-in investment and $4.7k low end scream micro-operator, likely part-time, with no budget headroom and no urgency to automate. You sell into budget, and Budget Blinds has it.

The terrain advantage flips the usual script. DNA Unlimited’s approved-supplier model looks like an open door for POS or marketing automation, but when the average unit revenue is that low, “open procurement” just means they can buy anything—and will buy nothing. Budget Blinds’ franchisor-controlled stack is a gate, not a wall: it signals a centralized tech mandate, which means if you land the franchisor, you land 1,355 units in one motion. That’s a tighter sales cycle with higher ACV, versus chasing 3,786 low-revenue independents who’ll churn before year two.

The tradeoff is total addressable market versus qualified addressable market. DNA Unlimited gives you a bigger spreadsheet number, but Budget Blinds gives you a list of owners who actually need software to run a $775k operation and can write the check. Timing seals it: Budget Blinds’ current FDD means their unit economics and tech stack are fresh and actionable right now, while DNA Unlimited’s stale filing introduces compliance risk and outdated financials you’d be selling blind into.

Verdict: Budget Blinds wins on budget depth, centralized terrain, and deal-cycle timing—ignore the unit-count mirage.